United States · FDA National Drug Code directory
Magnilife Psoriasis Care
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43689-0036_55916b33-840a-ef74-e063-6294a90af75f
- Product NDC
- 43689-0036
- Form
- CREAM
- Composition / generic term
- GRAPHITE, DAPHNE MEZEREUM BARK,
- Labeler
- The Magni Group, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20260629
- Source listing expiry
- 20271231
Source-listed ingredients
- GRAPHITE — 3 [hp_X]/g
- DAPHNE MEZEREUM BARK — 6 [hp_X]/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 JAR in 1 BOTTLE, UNIT-DOSE (43689-0036-2) / 56 g in 1 JAR · 43689-0036-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →